|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 38/1841 | (2013.01) | ||
| A61K 38/18 | (2006.01) | ||
| C07K2319/31 | (2013.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61K 38/00 | (2013.01) | ||
| A61K 38/1796 | (2013.01) |
| (11) | Patento numeris | 3380121 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16869255.6 |
| Europos patento paraiškos padavimo data | 2016-11-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-12-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/063557 |
| Data | 2016-11-23 |
| (87) | Numeris | WO 2017/091706 |
| Data | 2017-06-01 |
| (30) | Numeris | Data | Šalis |
| 201562258934 P | 2015-11-23 | US |
| (72) |
SHERMAN, Matthew, L. , US
ATTIE, Kenneth, M. , US
|
| (73) |
Acceleron Pharma Inc. ,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | ACTRII ANTAGONIST FOR USE IN TREATING EYE DISORDERS |
| ACTRII ANTAGONIST FOR USE IN TREATING EYE DISORDERS |